HIGHFDA DEVICE

Mindray BeneVision N1 Patient Monitor Recall Issued for 2,278 Units Worldwide (2025)

Mindray DS USA, Inc. dba Mindray North America recalled 2,278 BeneVision N1 patient monitors distributed worldwide, including Canada. The devices may activate an abnormal alarm pause. Hospitals and clinicians should stop using the devices immediately and follow the recall instructions issued by Mindray.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
August 15, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 15, 2025
Hazard Level
HIGH
Brands
Mindray, Mindray DS USA, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Mindray, Mindray DS USA, Inc.
Product type
Patient Monitor
Model numbers
6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00018, 6660E-PA00015, 6660E-PA00020, Q6660E-PA00011 +13 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 15, 2025

  2. Reported by FDA DEVICE

    October 1, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Potential for activation of an abnormal alarm pause.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Mindray DS USA, Inc. dba Mindray North America or your healthcare provider for instructions. Notification method: Letter

About This Product

BeneVision N1 is a patient monitor intended to display, review, store, alarm and transfer multiple physiological parameters.

Why This Is Dangerous

The defect could cause an abnormal alarm pause, potentially delaying alarms to clinicians and affecting timely responses.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Hospitals and clinicians may need to halt use of the affected devices until remediation, which could affect patient monitoring workflows and require device swaps.

Practical Guidance

How to identify if yours is affected

  1. Compare your device model numbers to the list in the recall notice.
  2. Check software version for compatibility with the affected units.
  3. Inspect labeling on the device for the model numbers listed in the recall.

Where to find product info

Refer to the FDA enforcement notice for the official list of models and part numbers.

What timeline to expect

Remediation timelines vary by facility but recalls typically involve 4-8 weeks for replacement or repair processes.

If the manufacturer is unresponsive

  • Escalate to hospital device management and the manufacturer recall contact
  • File a formal complaint with the FDA if the device remains in use after recall notice

How to prevent similar issues

  • When purchasing patient monitors, verify model numbers and software versions match the current recall lists
  • Document all equipment serials and keep updated inventories
  • Engage with hospital procurement to ensure device recalls are integrated into asset management

Documentation advice

Keep the recall notification, model numbers, serials, purchase records, and all correspondence with the manufacturer for future reference.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Models: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00018, 6660E-PA00015, 6660E-PA00020, Q6660E-PA00011, 6660E-PA00021, 6660E-PA00016, 6660E-PA00019, Q6660E-PA00018, 6660E-PA00010, Q6660E-PA00010, Q6660E-PA00021, Q6660E-PA00012, 6660E-PA00030, 6660E-PA00041, 6660E-PA00035, 6660E-PA00032, 6660E-PA00031 Software Versions: 1.04.00.01, 01.05.00.01, 01.06.00.01, 01.06.01.01 Sold Worldwide with Canada included Remedy: Stop using the device immediately and follow manufacturer recall instructions Manufacturer: Mindray DS USA, Inc. dba Mindray North America Recall Date: 2025-08-

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Worldwide distribution including Canada
  • Alarm pause defect in BeneVision N1
  • Class II medical device recall
  • Active recall as of 2025-08-15
  • FDA enforcement reference Z-2622-2025

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTGENERAL
Injury Types
OTHER

Product Details

Model Numbers
6660E-PA00017
6660E-PA00014
6660E-PA00012
6660E-PA00011
6660E-PA00018
+16 more
Affected States
ALL
Report Date
October 1, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more